Glycosaminoglycans: key players in cancer cell biology and treatment. - Wikidata - wikimedia - TriplyDB

Glycosaminoglycans: key players in cancer cell biology and treatment.

Glycosaminoglycans: key players in cancer cell biology and treatment.

http://www.wikidata.org/entity/Q37983930

about

Crystal structures of β-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding Glycosylated Notch and Cancer Marine Origin Polysaccharides in Drug Delivery Systems.Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery Diverse Roles of Heparan Sulfate and Heparin in Wound Repair Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1 Extracellular Matrix, a Hard Player in Angiogenesis Insights into the key roles of proteoglycans in breast cancer biology and translational medicine Reconstruction of Tissue-Specific Metabolic Networks Using CORDA Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma "On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients Glycosaminoglycans detection methods: Applications of mass spectrometry.Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.ScFv anti-heparan sulfate antibodies unexpectedly activate endothelial and cancer cells through p38 MAPK: implications for antibody-based targeting of heparan sulfate proteoglycans in cancer.Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion Heparan sulfate mediates trastuzumab effect in breast cancer cells CHST11 gene expression and DNA methylation in breast cancer Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancer.Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation.Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.A network-based pathway-expanding approach for pathway analysis.Middle region of the Borrelia burgdorferi surface-located protein 1 (Lmp1) interacts with host chondroitin-6-sulfate and independently facilitates infection.An introduction to proteoglycans and their localization The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.Propolis induces chondroitin/dermatan sulphate and hyaluronic Acid accumulation in the skin of burned wound.Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.Xyloside-primed Chondroitin Sulfate/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects in Vitro.Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.

P2860

Q24336888-B4D37D2E-D0CC-4E8B-B711-6F433EFD9C76 Q26765743-0179FD8B-D06B-41FC-9F7C-5265D9224A77 Q26767227-F5B6E50C-45A0-4764-8F94-ED1F9C8BE651 Q26786070-1BEDC47C-F48C-4A6F-846D-96EF58B778A4 Q26799832-3A6E4792-E005-40B4-A55A-FAAAB89D1FD1 Q26800001-F6226505-FE17-4549-9B8C-9212193E9055 Q26823441-FD5203F4-65AB-486C-9A60-B10E5B62C331 Q27347532-634E3427-5718-4E5D-B99D-C6048E324D99 Q27973758-59C402A5-80FF-415A-829E-C0082E363EF1 Q28072886-2C837CBA-11CD-47A0-B94A-5E33A8B839C6 Q28085548-70B05AF2-3543-43CB-AB84-1C4064916FF6 Q28388815-2B581EEF-004E-4D0D-BB1C-F271CA950D25 Q28552442-EA130DFE-8588-4E9C-9725-1FCDB7E5ABEA Q28828562-FEA89353-5CC2-47C7-9C6A-9A0840E7D42D Q33568125-7F2A2C5D-16B7-4B6A-9B2C-4AFE3613E80A Q33674704-8A6D200C-8A6A-4039-9979-83EF13729A1E Q33777572-59AF4F6E-5245-4DCD-975E-B47DBAE3A7DC Q33816146-149C1426-2347-48D1-860A-3AB00F6777A5 Q33831191-96DA10FC-7586-4543-AD98-4AECF86C4799 Q34031745-47CEAB31-154F-48CE-88C6-51E2ED2A5132 Q34075861-88C86A1E-B2AE-4F13-A0D5-88698737710A Q34477717-C313C2DA-C3E4-4BDD-AABA-C75ED358315D Q34598261-2ABD17B2-1839-4711-8690-9657AA63E5BA Q35003529-ED6A32CD-3BD8-47A8-85FF-4573CCB1A1A4 Q35073326-981543E6-44D6-48D1-AD98-5F3BA252E4A6 Q35172654-C284543F-1ECB-4A9E-8605-7795B4616F56 Q35224992-90DBE130-E074-4703-984F-6E55E53B3393 Q35519929-45B5D499-6AE2-4013-AF01-622FEAD74427 Q36048885-A63B253F-3939-418B-B829-A1305EB82F51 Q36064013-E73C7C19-97C4-4FAE-A14D-010DDD16603F Q36255478-FAE24D3F-C0A1-4182-8841-28184A180A7B Q36268645-D5339029-E09A-44AC-B2B2-40D3206F029E Q36480061-DF52E2D6-FDF0-436B-B722-745F50E803D7 Q36481630-D86A66EA-34DE-4969-9C4A-0CD83D00159E Q36530735-906FEACD-BC80-4EF0-B372-6934D13C368B Q36544364-45A55017-7245-47F3-B70B-2CB02D3984DF Q36711687-E28A1128-CE0A-41A9-85BB-888F9693C60E Q36836945-38A99886-47F7-459E-AEA9-E1C8D6776198 Q37078727-55A7F894-F181-49A1-812B-280340F1E0CE Q37114695-1B728615-2E88-4783-A233-B109367572A8

P2860

Glycosaminoglycans: key players in cancer cell biology and treatment.

http://www.wikidata.org/entity/Q37983930

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Glycosaminoglycans: key players in cancer cell biology and treatment.

@en

Glycosaminoglycans: key players in cancer cell biology and treatment.

@nl

type

label

Glycosaminoglycans: key players in cancer cell biology and treatment.

@en

Glycosaminoglycans: key players in cancer cell biology and treatment.

@nl

prefLabel

Glycosaminoglycans: key players in cancer cell biology and treatment.

@en

Glycosaminoglycans: key players in cancer cell biology and treatment.

@nl

P1433

Q37983930-9967C4F0-1D59-445B-9206-F7ABCD2380F8

P1476

Q37983930-976B68FC-039A-47B5-BD2B-E2748517E41A

P2093

Q37983930-25F4EEB5-17D8-4F81-A04C-4600ADBE4C0C

Q37983930-5BA5E01B-3CD6-441C-A95E-CCC4CE4D8940

Q37983930-6017CA46-41B9-4EC0-995F-B8671EB7FE35

Q37983930-738348EF-BF94-4CFB-AFFE-39B7BB445FBA

Q37983930-A3C0D991-A411-4369-A3DB-312F12463612

Q37983930-C8B65CE1-D92A-4DB0-91A7-A4AC03A0C76B

Q37983930-E8A8794E-8FD9-42DF-B3FC-70F008ED339B

Q37983930-F082A35C-76A6-47AF-B75C-104CB609A85F

Q37983930-F37B7565-059D-4340-8847-4BA6D0999DF1

P2860

Q37983930-020CAE96-3659-404D-B16A-3F9834B80282

Q37983930-0282B869-60B9-423E-8547-8A264BE6E492

Q37983930-03E36955-D5E8-4A41-A232-5148CB04AE9B

Q37983930-05720B0A-9AA2-4C3D-AC69-5D1E38A5030D

Q37983930-0863DDF9-7F54-4291-A7C1-1D853D73AF74

Q37983930-0D6F97C8-6917-4D02-8AE6-58B3BE250208

Q37983930-0E52888D-AB7A-4D9E-9283-41CA052F3930

Q37983930-0FB98254-F466-4E14-820E-A9D81DADE1A8

Q37983930-120DB8F1-8F61-49B4-913F-E4D381771002

Q37983930-1415603A-A356-4326-908D-E1E0E7EE50CB

P304

Q37983930-5D048CBF-0747-4798-B226-4FECA5CF3D2F

P31

Q37983930-895991A0-6B8D-4902-BA48-E964A4120858

P356

Q37983930-7847A4A6-D78A-4FD2-961B-C2FDF0631E24

P407

Q37983930-352BBFEC-50AB-42EA-B293-5999221F4924

P433

Q37983930-088D3B8F-AAD5-4DCC-BBF8-82FF214ACD0C

P478

Q37983930-146167C9-9051-4F45-B231-1E842D68073D

P577

Q37983930-8C7903B7-7681-4415-BE61-780293D1EE4B

P5875

Q37983930-3BB236BD-21CC-412D-9F5C-D2606328E74B

P698

Q37983930-EDF0F583-889E-4AF6-B992-1CE17498FAB0

P356

J.1742-4658.2012.08529.X

P1433

P1476

Glycosaminoglycans: key players in cancer cell biology and treatment.

@en

P2093

Achilleas D Theocharis

http://www.w3.org/2001/XMLSchema#string

Chrisostomi Gialeli

http://www.w3.org/2001/XMLSchema#string

Dragana Nikitovic

http://www.w3.org/2001/XMLSchema#string

Evgenia Karousou

http://www.w3.org/2001/XMLSchema#string

George N Tzanakakis

http://www.w3.org/2001/XMLSchema#string

Mauro S Pavão

http://www.w3.org/2001/XMLSchema#string

Nikos Afratis

http://www.w3.org/2001/XMLSchema#string

Nikos K Karamanos

http://www.w3.org/2001/XMLSchema#string

Theodore Tsegenidis

http://www.w3.org/2001/XMLSchema#string

P2860

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway

HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase

Inflammation and cancer

Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma

Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma

P304

1177-1197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-4658.2012.08529.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221831288

http://www.w3.org/2001/XMLSchema#string

P698

22333131

http://www.w3.org/2001/XMLSchema#string